Similar Items: Serum Advanced Glycation End Products as Drivers of Poor Tendon Outcomes in Diabetes? An Emerging Hypothesis and Narrative Review
- Association Between Dietary Advanced Glycation End Products (AGEs) and Pancreatic Fat Accumulation: Evidence From a Case–Control Study
- Prevalence and predictors of poor glycemic control in patients with type 2 diabetes mellitus attending Alexandria Main University Hospital
- Overview of Cellular Transplantation in Diabetes Mellitus: Focus on the Metabolic Outcome
- Effects of Low-Dose Pioglitazone on Serum Levels of Adiponectin, Dehydroepiandrosterone, Amyloid Beta Peptide, and Lipid Profile in Elderly Japanese People with Type 2 Diabetes
- Sarcopenia and sarcopenic obesity in type 2 diabetes mellitus and cardiovascular disease: current perspective and narrative review
- Preliminary Outcomes of a Brief Values‐Guided Self‐Management Intervention to Improve Glucose Levels Among Emerging Adults With Type 1 Diabetes and Above‐Recommended HbA1c: A Pilot Study